Multiple Sclerosis Research Repository

1. Long-term drug treatment in multiple sclerosis: safety success and concerns”: Jakimovski D et al

-Two-year-long trials are unable to fully capture the positive and negative effects of immune system modulation and reconstitution. 

-During the process of shared DMT decision, both MS care providers and their patients should be aware of an ever-expanding number of drug-based adverse events and their influence on the risk-benefit analysis.